MPC-531

N/A

Report date: 2024/12/10 15:07:36

Base Information

Drug NameMPC-531
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionVirus DNA polymerase inhibitorsReverse transcriptase inhibitors
TargetsVirus DNA polymeraseReverse transcriptase
Therapy Area/IndicationsEpstein-Barr Virus InfectionsCytomegalovirus InfectionsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicroprobe Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsEpstein-Barr Virus InfectionsCytomegalovirus InfectionsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A